The Trend of the Treatment of Advanced Hepatocellular Carcinoma: Combination of Immunotherapy and Targeted Therapy

2024-9-11

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer

2024-8-17

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer

2024-8-15

Management Approaches for High-Risk Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Updated Review

2024-8-5

Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)

2024-8-5

Gastrointestinal Cancer Therapy and Cardiotoxicity

2024-8-5

Neuropathic Pain in Cancer: What Are the Current Guidelines?

2024-8-5

Recent Advances in Liver Transplantation for Hepatocellular Carcinoma

2024-8-1

Modern Management of Gastric Neuroendocrine Neoplasms

2024-7-31

Opportunities and Challenges in Soft Tissue Sarcoma Risk Stratification in the Era of Personalised Medicine

2024-7-30

Small Cell Lung Cancer—An Update on Chemotherapy Resistance

2024-7-27

Advancements in Melanoma Therapies: From Surgery to Immunotherapy

2024-7-27

Systemic Management of Advanced Adrenocortical Carcinoma

2024-7-27

Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review

2024-7-27

Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer

2024-7-27

Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy

2024-7-25

Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation

2024-7-25

Treatment Options for Brain Metastases

2024-7-22

Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients

2024-6-25

Neoadjuvant Immunotherapy in Non-melanoma Skin Cancers of the Head and Neck

2024-6-25

Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management

2024-6-24

An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas

2024-6-19

Targeted Therapies in Low-Grade Serous Ovarian Cancers

2024-6-13

External Beam Radiotherapy in the Management of Uveal Melanoma

2024-6-13

Promising Therapeutic Targets for Recurrent/Metastatic Anaplastic Thyroid Cancer

2024-6-12

Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies

2024-6-12

Current Treatment Options: Uterine Sarcoma

2024-5-31

Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome

2024-5-30

What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?

2024-5-29

Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers

2024-5-18

Correction to: Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer

2024-5-18

What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?

2024-5-16

Genetic Predisposition to Sarcoma: What Should Clinicians Know?

2024-5-7

Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors

2024-5-2

Post-Radiotherapy Dysphagia in Head and Neck Cancer: Current Management by Speech-Language Pathologists

2024-5-1

Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods

2024-4-27

Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?

2024-4-24

Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine

2024-4-24

Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?

2024-4-23

Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer

2024-4-20

Photodynamic application in diagnostic procedures and treatment of non-melanoma skin cancers

2024-4-6

Role of Metastasis-Directed Therapy in Genitourinary Cancers

2024-4-4

HER2-Positive Metastatic Colorectal Cancer

2024-3-28

Pioneering the Way: The Revolutionary Potential of Antibody–Drug Conjugates in NSCLC

2024-3-23

Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation

2024-3-22

Social Determinants of Health and the Link to Colorectal Cancer Outcomes

2024-3-18

Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma

2024-3-13

Ovarian Suppression: Early Menopause and Late Effects

2024-3-13

Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies

2024-3-12

Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose

2024-2-22